Morrison Scott W 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Sep 16, 2025
Insider Transaction Report
Form 4
Morrison Scott W
Director
Transactions
- Exercise/Conversion
Common Stock
2025-09-15+1,334→ 4,684 total - Exercise/Conversion
Restricted Stock Units
2025-09-15−1,334→ 0 total→ Common Stock (1,334 underlying)
Holdings
- 6,016(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]The Reporting Person is trustee of the Morrison-Minton Family 2004 Trust, and the Reporting Person and his spouse are the sole beneficiaries of the trust.
- [F3]The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.